...E. et al. Nat. Commun. ; published online July 31, 2018 doi:10.1038/s41467-018-05385-0 CONTACT: Lluís Espinosa, Hospital del Mar...
...email: abigas@imim.es CONTACT: Christian W. Siebel, Genentech Inc., South San Francisco, Calif. email: siebel.christian@gene.com Jennie Walters Genentech Inc. Hospital del Mar Jagged...

...Argentina email: gabyrabi@gmail.com CONTACT: Pilar Navarro, Hospital del Mar Medical Research Institute, Barcelona, Spain email: pnavarro@imim.es Elizabeth S. Eaton Hospital del Mar National...

...Hospital del Mar, via its Hospital del Mar Medical Research Institute (IMIM) tech transfer office, and the university...
...declined to disclose financial terms, and the hospital and university did not respond to inquiries. Hospital del Mar...

...Merck KGaA (Xetra:MRK, Darmstadt, Germany) market cetuximab as Erbitux . Biocartis S.A. , Lausanne, Switzerland Hospital del Mar...

...why ficlatuzumab appeared more active in this subgroup. Edurne Arriola, a medical oncologist at the Hospital del Mar...
...Takeda Pharmaceutical Co. Ltd. It is in Phase I testing in solid tumors. Arriola of Hospital del Mar...
...Denmark Galaxy Biotech LLC , Mountain View, Calif. Genentech Inc. , South San Francisco, Calif. Hospital del Mar...

...Montagut, C. et al. Nat. Med.; published online Jan. 22, 2012; doi:10.1038/nm.2609 Contact: Joan Albanell, Hospital del Mar...

...al. Proc. Natl. Acad. Sci. USA; published online March 23, 2009; doi:10.1073/pnas.0813221106 Contact: Anna Bigas, IMIM-Hospital del Mar...